What is he best known for?
The fields of study he is best known for:
His primary areas of investigation include Genetics, Melanoma, Germline mutation, CDKN2A and Cutaneous melanoma.
The subject of his Melanoma research is within the realm of Cancer research.
His Cancer research research includes themes of Bioinformatics, Transcription factor, Oncogene, Chromatin and microRNA.
The study incorporates disciplines such as Telomere, Point mutation, Family history and Germline in addition to Germline mutation.
The concepts of his Oncology study are interwoven with issues in Cancer, Performance status, Pathology, Genotype and Ipilimumab.
His work carried out in the field of Gene brings together such families of science as Binimetinib, Subclass and Adenocarcinoma.
His most cited work include:
- Genomic Classification of Cutaneous Melanoma (1491 citations)
- Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma (758 citations)
- Pan-cancer analysis of whole genomes (538 citations)
What are the main themes of his work throughout his whole career to date?
His scientific interests lie mostly in Melanoma, Cancer research, Genetics, Internal medicine and CDKN2A.
His study in Melanoma focuses on Cutaneous melanoma in particular.
His Cutaneous melanoma study incorporates themes from Dermatology, Nevus, Case-control study and MEDLINE.
His study in Cancer research is interdisciplinary in nature, drawing from both Exome sequencing, Cell cycle, Loss of heterozygosity and p14arf.
His Internal medicine research is multidisciplinary, incorporating elements of Oncology and Pathology.
The various areas that he examines in his Oncology study include Stage and Bioinformatics.
He most often published in these fields:
- Melanoma (60.32%)
- Cancer research (29.84%)
- Genetics (25.71%)
What were the highlights of his more recent work (between 2017-2021)?
- Melanoma (60.32%)
- Cutaneous melanoma (20.00%)
- Cancer research (29.84%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Melanoma, Cutaneous melanoma, Cancer research, Internal medicine and Oncology.
His Melanoma research entails a greater understanding of Genetics.
His studies deal with areas such as Genome-wide association study, MEDLINE, Case-control study, Germline and CDKN2A as well as Cutaneous melanoma.
Graham J. Mann studied CDKN2A and Genetic testing that intersect with Germline mutation and Genetic counseling.
Graham J. Mann has included themes like Microvesicles, microRNA, Gene and Gene mutation in his Cancer research study.
His Oncology research is multidisciplinary, relying on both Cancer, Adenocarcinoma and Confidence interval.
Between 2017 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- Genomic and Functional Approaches to Understanding Cancer Aneuploidy (296 citations)
- Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060)) (147 citations)
In his most recent research, the most cited papers focused on:
His main research concerns Melanoma, Cancer research, Cutaneous melanoma, Cancer and Internal medicine.
His Melanoma research is multidisciplinary, incorporating perspectives in Metastasis and Neuroblastoma RAS viral oncogene homolog.
His Cutaneous melanoma study is concerned with the field of Genetics as a whole.
His Genetics study focuses on Germline mutation in particular.
His Cancer research includes elements of Mutation and Gene regulatory network.
His Internal medicine research is multidisciplinary, relying on both Gene, Oncology, MAPK/ERK pathway and Gene expression profiling.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
